Healthy volunteers help compare new semaglutide tablet to current version
NCT ID NCT05784402
First seen Nov 01, 2025 · Last updated May 13, 2026 · Updated 23 times
Summary
This study tested a new formulation of the medicine semaglutide in healthy adults. The goal was to measure how much of the drug gets into the blood with the new tablet compared to the current one. About 264 participants took different doses daily for up to 21 weeks. The study is complete and helps researchers understand if the new tablet works similarly.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Altasciences Clinical Company, Inc
Montreal, Quebec, H3P 3P1, Canada
-
Altasciences Clinical Kansas, Inc.
Kansas City, Kansas, 66212, United States
-
Altasciences Clinical LA, Inc.
Cypress, California, 90630, United States
Conditions
Explore the condition pages connected to this study.